New pharmaceutical preparations approved for marketing abroad in 2020 mainly include oral preparations：oral liquids，films and orally disintegrating tablets convenient for taking，liquid preparations prepared by self-microemulsifying drug delivery system technology，which can improve bioavailability；compound tablets，controlled-release drugs，which will reduce the number of administrations，improve efficacy and the compliance of patients with medication；azacitidine and octreotide used to be only injections，and they are made into oral preparations to change the route of administration to facilitate treatment. Injections：drug nanospheres and sustained-release injections can improve efficacy；hyaluronidase-containing compound drug subcutaneous injections can shorten the administration time；three drug-antibody conjugate injections can improve drug targeting and achieve precise treatment goals. External preparations：lotions，creams，ointments and gels are easy to use；transdermal controlled-release patches can control drug release；nasal sprays achieve systemic treatment through local administration；it is predicted that the peak annual sales of compound indacaterol acetate/glycopyrronium bromide/mometasone furoate inhalation after its launch will exceed US＄1 billion.